Skip to main content
Erschienen in: World Journal of Urology 8/2016

15.12.2015 | Original Article

Lymphadenopathies in patients with renal cell carcinoma: clinical and pathological predictors of pathologically confirmed lymph node invasion

verfasst von: Umberto Capitanio, Federico Deho’, Paolo Dell’Oglio, Alessandro Larcher, Paolo Capogrosso, Alessandro Nini, Cristina Carenzi, Massimo Freschi, Alberto Briganti, Andrea Salonia, Francesco Montorsi, Roberto Bertini

Erschienen in: World Journal of Urology | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Introduction

In renal cell carcinoma (RCC), lymph node status at preoperative imaging is affected by a non-negligible false-positive rate. We aimed to investigate which factors are related to a concordance between clinical suspicion and pathological confirmation of lymph node invasion (LNI).

Methods

At a single tertiary care institution, 2954 RCC patients underwent either partial or radical nephrectomy. For the aim of the study, only clinically positive lymph node cases were included (cN1). Statistical analyses assessed the concordance between preoperative and pathological nodal status.

Results

Preoperative axial CT scans revealed 424 (14.4 %) patients showing at least one enlarged lymph node suspected for LNI (cN1). All lymphadenopathies were removed at surgery, and LNI was pathologically confirmed (pN1) in 122 patients (28.8 %). When focusing the analyses on clinical characteristics (variables known before surgery), metastases at diagnosis [OR 3.0 (95 %1.9–4.8), p < 0.001] and tumor size [OR 1.1 (95 % 1.1–1.2), p < 0.001] were the two most informative predictors of concordance between clinical and pathological nodal status. Concordance was also more likely in patients with papillary type II tumors (55.6 %) relative to papillary type I (38.1 %), clear cell (27.7 %) and chromophobe (8.3 %) tumors. At multivariable analyses, none of the considered blood markers resulted to be independently associated with LNI.

Conclusions

Roughly 70 % of patients showing a suspected lymph node preoperatively do not show LNI at the final pathological report. Among patients with clinically positive nodes, clinical tumor size and metastases at diagnosis represent the most informative and independent predictors of confirmed LNI at final pathology.
Literatur
1.
Zurück zum Zitat Network NCC (2015) NCCN clinical practice guidelines in kidney cancer. 12 Sept 2014: Version 3.2015 Network NCC (2015) NCCN clinical practice guidelines in kidney cancer. 12 Sept 2014: Version 3.2015
2.
Zurück zum Zitat Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders P, Powles T, Staehler M, Volpe A, Bex A (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67(5):913–924. doi: 10.1016/j.eururo.2015.01.005 CrossRefPubMed Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders P, Powles T, Staehler M, Volpe A, Bex A (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67(5):913–924. doi: 10.​1016/​j.​eururo.​2015.​01.​005 CrossRefPubMed
4.
Zurück zum Zitat Briganti A, Abdollah F, Nini A et al (2012) Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection. Eur Urol 61:1132–1138CrossRefPubMed Briganti A, Abdollah F, Nini A et al (2012) Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection. Eur Urol 61:1132–1138CrossRefPubMed
5.
Zurück zum Zitat Studer UE, Scherz S, Scheidegger J et al (1990) Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol 144:243–245PubMed Studer UE, Scherz S, Scheidegger J et al (1990) Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol 144:243–245PubMed
6.
Zurück zum Zitat Capitanio U, Becker F, Blute ML et al (2011) Lymph node dissection in renal cell carcinoma. Eur Urol 60:1212–1220CrossRefPubMed Capitanio U, Becker F, Blute ML et al (2011) Lymph node dissection in renal cell carcinoma. Eur Urol 60:1212–1220CrossRefPubMed
7.
Zurück zum Zitat Ljungberg B, Cowan NC, Hanbury DC et al (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58:398–406CrossRefPubMed Ljungberg B, Cowan NC, Hanbury DC et al (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58:398–406CrossRefPubMed
8.
Zurück zum Zitat Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA (1982) Evaluating the yield of medical tests. JAMA 14(247):2543–2546CrossRef Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA (1982) Evaluating the yield of medical tests. JAMA 14(247):2543–2546CrossRef
9.
Zurück zum Zitat Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 28(15):361–387CrossRef Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 28(15):361–387CrossRef
10.
Zurück zum Zitat Connolly SS, Raja A, Stunell H et al (2015) Diagnostic accuracy of preoperative computed tomography used alone to detect lymph-node involvement at radical nephrectomy. Scand J Urol 49:142–148CrossRefPubMed Connolly SS, Raja A, Stunell H et al (2015) Diagnostic accuracy of preoperative computed tomography used alone to detect lymph-node involvement at radical nephrectomy. Scand J Urol 49:142–148CrossRefPubMed
11.
Zurück zum Zitat Pushkar P, Agarwal A, Sarin A, Kashyap V (2015) Concurrent RCC with tuberculous para-aortic lymphadenopathy: a pleasant surprise. Can Urol Assoc J 9:E210-2CrossRefPubMed Pushkar P, Agarwal A, Sarin A, Kashyap V (2015) Concurrent RCC with tuberculous para-aortic lymphadenopathy: a pleasant surprise. Can Urol Assoc J 9:E210-2CrossRefPubMed
12.
Zurück zum Zitat Lughezzani G, Capitanio U, Jeldres C, Isbarn H, Shariat SF, Arjane P, Widmer H, Perrotte P, Montorsi F, Karakiewicz PI (2009) Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: a population-based perspective. Cancer 115(24):5680–5687. doi: 10.1002/cncr.24682 CrossRefPubMed Lughezzani G, Capitanio U, Jeldres C, Isbarn H, Shariat SF, Arjane P, Widmer H, Perrotte P, Montorsi F, Karakiewicz PI (2009) Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: a population-based perspective. Cancer 115(24):5680–5687. doi: 10.​1002/​cncr.​24682 CrossRefPubMed
13.
14.
Zurück zum Zitat Blom JH, van Poppel H, Marechal JM et al (2009) Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol 55:28–34CrossRefPubMed Blom JH, van Poppel H, Marechal JM et al (2009) Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol 55:28–34CrossRefPubMed
15.
Zurück zum Zitat Capitanio U, Suardi N, Matloob R et al (2014) Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC). BJU Int 114:210–215CrossRefPubMed Capitanio U, Suardi N, Matloob R et al (2014) Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC). BJU Int 114:210–215CrossRefPubMed
16.
Zurück zum Zitat Whitson JM, Harris CR, Reese AC, Meng MV (2011) Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastases. J Urol 185:1615–1620CrossRefPubMed Whitson JM, Harris CR, Reese AC, Meng MV (2011) Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastases. J Urol 185:1615–1620CrossRefPubMed
18.
Zurück zum Zitat Kroeger N et al (2012) Clinical, molecular, and genetic correlates of lymphatic spread in clear cell renal cell carcinoma. Eur Urol 61(5):888–895CrossRefPubMed Kroeger N et al (2012) Clinical, molecular, and genetic correlates of lymphatic spread in clear cell renal cell carcinoma. Eur Urol 61(5):888–895CrossRefPubMed
19.
Zurück zum Zitat Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247CrossRefPubMed Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247CrossRefPubMed
Metadaten
Titel
Lymphadenopathies in patients with renal cell carcinoma: clinical and pathological predictors of pathologically confirmed lymph node invasion
verfasst von
Umberto Capitanio
Federico Deho’
Paolo Dell’Oglio
Alessandro Larcher
Paolo Capogrosso
Alessandro Nini
Cristina Carenzi
Massimo Freschi
Alberto Briganti
Andrea Salonia
Francesco Montorsi
Roberto Bertini
Publikationsdatum
15.12.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 8/2016
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-015-1747-5

Weitere Artikel der Ausgabe 8/2016

World Journal of Urology 8/2016 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.